These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38115553)

  • 21. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
    Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
    Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative chemotherapy is associated with prognosis of stage IV colorectal cancer treated with preoperative chemotherapy/chemoradiotherapy and curative resection.
    Nozawa H; Sonoda H; Ishii H; Emoto S; Murono K; Kaneko M; Sasaki K; Nishikawa T; Shuno Y; Tanaka T; Kawai K; Hata K; Ishihara S
    Int J Colorectal Dis; 2020 Jan; 35(1):177-180. PubMed ID: 31807855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of tumor deposits combined with lymph node metastasis in stage III colorectal cancer patients: a retrospective multi-center cohort study from China.
    Pu H; Pang X; Fu J; Zheng R; Chen Y; Zhang D; Fang X
    Int J Colorectal Dis; 2022 Jun; 37(6):1411-1420. PubMed ID: 35595975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological Characteristics and Outcome of Adolescent and Young Adult-Onset Microsatellite Stable Colorectal Cancer Patients.
    Sukhokanjanachusak K; Pongpaibul A; Nimmannit A; Akewanlop C; Korphaisarn K
    J Adolesc Young Adult Oncol; 2021 Oct; 10(5):573-580. PubMed ID: 33085547
    [No Abstract]   [Full Text] [Related]  

  • 25. Trends and Clinical Outcomes in Young-onset Colorectal Cancer Patients.
    Goh SS; Loo EX; Lee DJ
    Ann Acad Med Singap; 2020 Nov; 49(11):848-856. PubMed ID: 33381778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment.
    Ott C; Gerken M; Hirsch D; Fest P; Fichtner-Feigl S; Munker S; Schnoy E; Stroszczynski C; Vogelhuber M; Herr W; Evert M; Reng M; Schlitt HJ; Klinkhammer-Schalke M; Teufel A
    Digestion; 2018; 98(3):143-152. PubMed ID: 29870979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect and safety of intraoperative intraperitoneal chemotherapy on patients suffering from colorectal cancer.
    Shang A; Wang S; Yang Y; Li L; Zhao Z; Li D; Guo Y; Wang M
    World J Surg Oncol; 2021 Mar; 19(1):84. PubMed ID: 33752702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of sidedness of colorectal cancer on tumor immunity.
    Takasu C; Nishi M; Yoshikawa K; Tokunaga T; Kashihara H; Yoshimoto T; Shimada M
    PLoS One; 2020; 15(10):e0240408. PubMed ID: 33045001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Grade Inflammation Attenuates Chemosensitivity and Confers to Poor Survival of Surgical Stage III CRC Patients.
    Ying HQ; You XH; Liao YC; Sun F; Cheng XX
    Front Oncol; 2021; 11():580455. PubMed ID: 33968712
    [No Abstract]   [Full Text] [Related]  

  • 31. The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy.
    Min BH; Bae JM; Lee EJ; Yu HS; Kim YH; Chang DK; Kim HC; Park CK; Lee SH; Kim KM; Kang GH
    BMC Cancer; 2011 Aug; 11():344. PubMed ID: 21827707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poor prognosis of young patients with colorectal cancer: a retrospective study.
    Zhao L; Bao F; Yan J; Liu H; Li T; Chen H; Li G
    Int J Colorectal Dis; 2017 Aug; 32(8):1147-1156. PubMed ID: 28389779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining perineural invasion with staging improve the prognostic accuracy in colorectal cancer: a retrospective cohort study.
    Zhang B; Lin Y; Wang C; Chen Z; Huang T; Chen H; Wang G; Lan P; He X; He X
    BMC Cancer; 2023 Jul; 23(1):675. PubMed ID: 37464346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article.
    Yang L; Ma Q; Yu YY; Wang C; Meng WJ; Adell G; Albertsson M; Arbman G; Jarlsfelt I; Peng ZH; Li Y; Zhou ZG; Sun XF
    Medicine (Baltimore); 2014 Dec; 93(28):e266. PubMed ID: 25526455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.
    Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between poorly differentiated clusters and efficacy of 5-fluorouracil-based adjuvant chemotherapy in stage III colorectal cancer.
    Tajima Y; Shimada Y; Kameyama H; Yagi R; Okamura T; Kobayashi T; Kosugi SI; Wakai T
    Jpn J Clin Oncol; 2017 Apr; 47(4):313-320. PubMed ID: 28100684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer.
    Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Nishimura Y; Katoh H; Yamashita K; Watanabe M; Yamaguchi K
    J Gastrointest Surg; 2017 May; 21(5):867-878. PubMed ID: 28251467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.
    Bruun J; Sveen A; Barros R; Eide PW; Eilertsen I; Kolberg M; Pellinen T; David L; Svindland A; Kallioniemi O; Guren MG; Nesbakken A; Almeida R; Lothe RA
    Mol Oncol; 2018 Sep; 12(9):1639-1655. PubMed ID: 29900672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex-specific differences in colorectal cancer: A multicenter retrospective cohort study.
    Joo HJ; Lee HS; Jang BI; Kim DB; Kim JH; Park JJ; Kim HG; Baek IH; Lee J; Kim B
    Cancer Rep (Hoboken); 2023 Aug; 6(8):e1845. PubMed ID: 37348877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of abdominal aortic calcification on the prognosis and recurrence of colorectal cancer stages II-III: A retrospective cohort study.
    Imaoka K; Shimomura M; Shimizu W; Akabane S; Ohira M; Imaoka Y; Yoshinaka H; Ono K; Mochizuki T; Matsubara K; Bekki T; Hattori M; Ohdan H
    Int J Colorectal Dis; 2023 Jan; 38(1):21. PubMed ID: 36680603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.